We measured PWS gene transcripts such as Snord116/SNORD116, SNRPN, and MAGEL2 in PWS patient-derived iPSCs, PWS patient iPSC-derived neurons, and mouse primary neurons to assess maternal activation with anti-EHMT2 RNAi and therapeutic feasibility. The gene discussed is MAGEL2; the disease is Prader-Willi syndrome.